Increasingly potent immunosuppressive agents have dramatically reduced the incidence of
rejection of transplanted organs while increasing susceptibility to opportunistic infections …

Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. In the United States, the Centers for Disease Control and …

Background Hepatitis C virus (HCV) infection is the leading indication for liver
transplantation worldwide, and interferon-containing regimens are associated with low …

Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …

Hepatitis C virus (HCV) infection is a substantial health problem worldwide. Most patients
infected with HCV remain chronically infected, with an increased risk of cirrhosis and …

Background/Aims: The natural history and predictors of HCV-related disease severity post-
transplantation are uncertain. The aims of this study were to define the natural history of post …

Background End-stage cirrhosis related to hepatitis C virus (HCV) is a common reason for
liver transplantation, although viremia is known to persist in most cases. We investigated the …

Metabolic processes utilize a variety of differing and contrasting biochemical routes to
enable synthesis of degradation and activation or deactivation of substances; in addition …

The natural history of clinically compensated hepatitis C virus (HCV) cirrhosis after liver
transplantation is unknown. This information is relevant to transplant centers to improve the …

Recurrent hepatitis occurs in the majority of patients undergoing liver transplantation for
hepatitis C virus (HCV) cirrhosis, with progression to cirrhosis in up to 30% after 5 years …